ClearPoint Neuro/CLPT

$6.50

-2.69%
-
1D1W1MYTD1YMAX

About ClearPoint Neuro

ClearPoint Neuro, Inc. is a commercial-stage medical device company. The Company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain. Its ClearPoint system is an integrated system comprised of hardware components, disposable components and intuitive, menu-driven software. Its hardware components consist primarily of a head fixation frame, computer workstation, and in-room monitor. Its disposable components for its ClearPoint system consist primarily of its SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Cannula. Its ClearPoint system software guides the physician in surgical planning, device alignment, navigation to the target and procedure monitoring. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance.

Ticker

CLPT

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Joseph Burnett

Employees

108

Headquarters

Solana beach, United States

ClearPoint Neuro Metrics

BasicAdvanced
$164.78M
Market cap
-
P/E ratio
-$0.89
EPS
0.88
Beta
-
Dividend rate

What the Analysts think about ClearPoint Neuro

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 3 analysts.
48.77% upside
High $11.00
Low $8.00
$6.50
Current price
$9.67
Average price target

ClearPoint Neuro Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-84.21% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$5.7M
-3.39%
Net income
$-4.8M
-31.43%
Profit margin
-84.21%
-29.02%

ClearPoint Neuro Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 20%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.18
-$0.23
-$0.29
-$0.20
-
Expected
-$0.20
-$0.19
-$0.19
-$0.25
-$0.20
Surprise
-10%
24.32%
52.63%
-20%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell ClearPoint Neuro stock

Buy or sell ClearPoint Neuro stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing